CORRESP Filing
PAVmed Inc.
Date: April 27, 2026 · CIK: 0001624326 · Accession: 0001493152-26-019087
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295202
Letter
PAVmed Inc.
Madison Avenue, 25th Floor
New York, New York 10017
April 27, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
F Street, N.E.
Washington, D.C. 20549
Attention: Margaret Sawicki
Re: PAVmed Inc.
Registration Statement on Form S-3
Filed April 21, 2026
File No. 333-295202
Ladies and Gentlemen:
PAVmed Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Wednesday, April 29, 2026, or as soon thereafter as practicable.
Very truly yours,
PAVMED INC.
Show Raw Text
CORRESP
1
filename1.htm
PAVmed
Inc.
360
Madison Avenue, 25th Floor
New
York, New York 10017
April
27, 2026
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Industrial Applications and Services
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Margaret Sawicki
Re:
PAVmed
Inc.
Registration
Statement on Form S-3
Filed
April 21, 2026
File
No. 333-295202
Ladies
and Gentlemen:
PAVmed
Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of
the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Wednesday, April
29, 2026, or as soon thereafter as practicable.
Very truly yours,
PAVMED INC.
By:
/s/
Lishan Aklog, M.D.
Name:
Lishan Aklog, M.D.
Title:
Chairman and Chief
Executive Officer